| Business Name: |
Lignamed LLC |
| Contact Person: |
M Christofidou-Solomidou |
| Address: |
3160 Chestnut St # 200, Philadelphia, Pennsylvania 19104 |
| Phone Number: |
(610) 631-1612 |
| Annual Revenue (USD): |
$0 to $49.999 |
| Founding Year: |
2013 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Commercial Biotechnical Research |
| SIC Code: |
8731 |
| NAICS Code: |
541711 |
| Share This Business: |
|
| Related Businesses: |
Oncovirx - Philadelphia, PA 19104
Intervir Therapeutics - Philadelphia, PA 19104
Diathera LLC - Philadelphia, PA 19104
Pathopartitions - Philadelphia, PA 19104
Vibe Pharmaceuticals - Philadelphia, PA 19104
Biotech Studio LLC - Philadelphia, PA 19104
Aum Lifetech Inc - Philadelphia, PA 19104
Metamorphosis LLC - Philadelphia, PA 19104
Microbiota Therapeutics - Philadelphia, PA 19104
Penzymes LLC - Philadelphia, PA 19104
Navirx LLC - Philadelphia, PA 19104
Betaplus Radiopharmaceuticals LLC - Philadelphia, PA 19104
Pathonomics - Philadelphia, PA 19104
Amyndas Biotherapeutics LLC - Philadelphia, PA 19104
Skelegen - Philadelphia, PA 19104
Cartcentric Diagnostics - Philadelphia, PA 19104
Liquid Biotech - Philadelphia, PA 19104
Epigen Cardio LLC - Philadelphia, PA 19104
Vector Biosystems - Philadelphia, PA 19104
|
The company Lignamed LLC provides B2B services in the form of Commercial Biotechnical Research from its single location in Pennsylvania.
1 to 4 employees work for Lignamed LLC, and the business now earns $0 to $49.999 per annum.
Lignamed LLC was launched in 2013 and is classified under SIC code and category 8731 , and NAICS number and grouping 541711 .
To contact Lignamed LLC, please call M Christofidou-Solomidou with the phone number (610) 631-1612 or visit its single location at 3160 Chestnut St # 200 in Philadelphia, Pennsylvania 19104.
The location of the single location can also be found using the coordinates 39.953553,-75.18659.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.